{{Chembox
| ImageFile = Aganodine.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = 2-(4,7-Dichloro-1,3-dihydroisoindol-2-yl)guanidine
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 86696-87-9
| PubChem = 176878
| ChEMBL = 2105912
| ChemSpiderID = 154051
| InChI=1S/C9H10Cl2N4/c10-7-1-2-8(11)6-4-15(3-5(6)7)14-9(12)13/h1-2H,3-4H2,(H4,12,13,14)
| InChIKey= DFKHOVYSCCPSHR-UHFFFAOYSA-N
| SMILES = C1C2=C(C=CC(=C2CN1N=C(N)N)Cl)Cl}}
|Section2={{Chembox Properties
| C=9 | H=10 | Cl=2 | N=4
| MolarMass = 245.109
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Aganodine''' is a [[guanidine]] that activates presynaptic [[imidazoline receptor]]s.<ref>{{cite journal|pmid=9298527|year=1997|last1=Molderings|first1=GJ|last2=Likungu|first2=J|last3=Jakschik|first3=J|last4=Göthert|first4=M|title=Presynaptic imidazoline receptors and non-adrenoceptor 3H-idazoxan binding sites in human cardiovascular tissues|volume=122|issue=1|pages=43–50|doi=10.1038/sj.bjp.0701343|pmc=1564902|journal=British Journal of Pharmacology}}</ref> Through its [[Agonist|agonism]] at imidazoline receptors, aganodine inhibits the presynaptic release of [[norepinephrine]].<ref name="Gothert Imidazoline-R Review">{{cite journal|last1=Göthert|first1=M.|last2=Brüss|first2=M.|last3=Bönisch|first3=H.|last4=Molderings|first4=G.J.|title=Presynaptic Imidazoline Receptors|journal=Annals of the New York Academy of Sciences|pages=171–184|accessdate=14 May 2017}}</ref>

==References==
{{reflist}}

[[Category:Guanidines]]
[[Category:Chloroarenes]]


{{pharma-stub}}